Regulatory T Cells and HIV-1 Infection

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Viral immunology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/vim.2008.0006PMID 18673076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of immune activation in HIV pathogenesis

  2007cited by this paper
• The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

  2007cited by this paper
• Impaired T Cell Receptor Signaling in Foxp3+ CD4 T Cells

  2007cited by this paper
• STAT5 signaling in normal and pathologic hematopoiesis.

  2007cited by this paper
• Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals

  2007cited by this paper
• Correlates of Preserved CD4+ T Cell Homeostasis during Natural, Nonpathogenic Simian Immunodeficiency Virus Infection of Sooty Mangabeys: Implications for AIDS Pathogenesis

  2007cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways

  2006cited by this paper
• Bystander T cell activation--implications for HIV infection and other diseases.

  2006cited by this paper
• Development and function of naturally occurring CD4+CD25+ regulatory T cells

  2006cited by this paper
• In vivo sites and cellular mechanisms of T reg cell–mediated suppression

  2006cited by this paper
• Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1.

  2006cited by this paper
• Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases?

  2006cited by this paper
• Regulatory T cells: present facts and future hopes

  2006cited by this paper
• HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Nef-mediated TCR-CD3 and MHC-I down-modulation prevents CD4+ T cell depletion in natural SIV infection

  2006cited by this paper
• Regulatory T cells

  2006cited by this paper
• T cells use two directionally distinct pathways for cytokine secretion

  2006cited by this paper
• IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

  2006cited by this paper
• Biology of CCR5 and its role in HIV infection and treatment.

  2006cited by this paper
• The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis.

  2005cited by this paper
• Viral and host factors in the pathogenesis of HIV infection.

  2005cited by this paper
• CD4+ t-cell depletion in hiv infection: Killed by friendly fire?

  2005cited by this paper
• Virus attachment and replication are promoted after acquisition of host CD28 and CD152 by HIV-1.

  2005cited by this paper
• Mechanisms of suppression by suppressor T cells

  2005cited by this paper
• In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients

  2005cited by this paper
• Fueling regulation: IL-2 keeps CD4+ Treg cells fit

  2005cited by this paper
• The dissociation between virological and immunological responses to HAART.

  2005cited by this paper
• Mechanisms of suppression by suppressor T cells

  2005cited by this paper
• In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

  2005cited by this paper
• Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

  2005cited by this paper
• Natural regulatory T cells in infectious disease

  2005cited by this paper
• Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure

  2004cited by this paper
• Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

  2004cited by this paper
• Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1

  2004cited by this paper
• HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells

  2004cited by this paper
• Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.

  2004cited by this paper
• Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy

  2004cited by this paper
• Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells

  2004cited by this paper
• Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

  2004cited by this paper
• CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1

  2004cited by this paper
• Human CD4+CD25+ regulatory T cells and infectious tolerance.

  2004cited by this paper
• Therapeutic vaccination using CD4 (cid:1) CD25 (cid:1) antigen-specific regulatory T cells

  2004cited by this paper
• A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

  2003cited by this paper
• Persistent immune activation in HIV-1 infection is associated with progression to AIDS

  2003cited by this paper
• Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

  2003cited by this paper
• Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.

  2003cited by this paper
• Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

  2003cited by this paper
• HIV and AIDS: 20 years of science

  2003cited by this paper
• Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

  2003cited by this paper
• Differential Impairment of Lytic and Cytokine Functions in Senescent Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes

  2003cited by this paper
• Twenty years of therapy for HIV-1 infection

  2003cited by this paper
• Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients.

  2002cited by this paper
• Expansion of activated human naïve T‐cells precedes effector function

  2002cited by this paper
• Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules

  2002cited by this paper
• Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.

  2002cited by this paper
• Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.

  2002cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• HIV and autoimmunity.

  2002cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• T-cell regulation by CD28 and CTLA-4

  2001cited by this paper
• Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection

  2001cited by this paper
• Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection

  2001cited by this paper
• Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy

  2001cited by this paper
• Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells

  2001cited by this paper
• T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

  2000cited by this paper
• Regulatory T cells: key controllers of immunologic self-tolerance.

  2000cited by this paper
• A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials Network.

  2000cited by this paper
• Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5

  2000cited by this paper
• CTLA4 ligation attenuates AP‐1, NFAT and NF‐κB activity in activated T cells

  1999cited by this paper
• Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

  1999cited by this paper
• CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells.

  1999cited by this paper
• Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

  1999cited by this paper
• Telomeres and HIV-1 infection: in search of exhaustion.

  1998cited by this paper
• Immune activation in the context of HIV infection

  1998cited by this paper
• HIV nef: the mother of all evil?

  1998cited by this paper
• Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Interferes with Extracellular Signal-regulated Kinase (ERK) and Jun NH2-terminal Kinase (JNK) Activation, but Does Not Affect Phosphorylation of T Cell Receptor ζ and ZAP70

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

  1996cited by this paper
• Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.

  1995cited by this paper
• Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion

  1995cited by this paper
• Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

  1995cited by this paper
• The Th1-Th2 hypothesis of HIV infection: new insights.

  1994cited by this paper
• Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

  1994cited by this paper
• A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

  1993cited by this paper
• Basic Immunology: Immune Mechanisms in Health and Disease

  1989cited by this paper
• The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

  1984cited by this paper
• T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV

  1984cited by this paper

• T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19

  2024cites this paper
• Association between Antiretroviral Treatment and Markers of Systemic Inflammation among HIV Patients in Ghana.

  2020cites this paper
• IFN-γ Attenuates Spontaneous Lymphocyte Proliferation by Fuelling Regulatory T Cells in HIV-1-Infected Patients

  2017cites this paper
• Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.

  2015cites this paper
• Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses

  2015cites this paper
• Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

  2014cites this paper
• Further Evidence That the Expression of CD38 and HLA-DR+ in CD8+ Lymphocytes Does Not Correlate to Disease Progression in HIV-1 Vertically Infected Children

  2012cites this paper
• Modeling Adaptive Regulatory T-Cell Dynamics during Early HIV Infection

  2012cites this paper
• Efficient CRM197-mediated drug targeting to monocytes.

  2012cites this paper
• Effects on Innate Immunity of a Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

  2012cites this paper
• HIV-Associated Immune Activation: From Bench to Bedside

  2011cites this paper
• Impact of HIV Infection and HAART Therapy on CD4 T Helper Cell Subset Expression and Function

  2011cites this paper
• Bachelor Biomedical Sciences

  2011cites this paper
• An antiviral immune response turning against the host in pathogenic HIV infection.

  2011cites this paper
• Revisiting the tolerogenicity of epidermal Langerhans cells

  2010cites this paper
• Molecular and biological aspects of the bovine immunodeficiency virus.

  2010cites this paper
• Subtle Mimicry of HLA by HIV-1 GP120 – A Role for Anti HLA Antibodies?

  2010cites this paper
• Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease

  2010cites this paper
• Percentage of regulatory T cells CD4+CD25+CD127- in HIV-infected patients is not reduced after cryopreservation.

  2010cites this paper
• CD8+HLA-G+ Regulatory T Cells Are Expanded in HIV-1-Infected Patients

  2009cites this paper